[Drug resistance of Mycobacterium leprae].
D000818:Animals; D002991:Clofazimine / Q000627:therapeutic use; D003622:Dapsone / Q000627:therapeutic use; D004352:Drug Resistance, Microbial / Q000235:genetics; D004359:Drug Therapy, Combination; D005000:Ethionamide / Q000627:therapeutic use; D006801:Humans; D007917:Leprostatic Agents / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D007918:Leprosy / Q000188:drug therapy; D051379:Mice; D008826:Microbial Sensitivity Tests; D009166:Mycobacterium leprae / Q000187:drug effects* / Q000235:genetics; D011515:Prothionamide / Q000627:therapeutic use
D007917:Leprostatic Agents; D011515:Prothionamide; D003622:Dapsone; D002991:Clofazimine; D005000:Ethionamide
Résistance médicamenteuse de Mycobacterium leprae.